Literature DB >> 33043078

Association Between Olfactory Impairment and Disease Severity and Duration in Parkinson's Disease.

Shoichi Sasaki1,2, Yoshiharu Horie3,4.   

Abstract

BACKGROUND: The association between olfactory dysfunction and disease duration and severity in Parkinson's disease (PD) remains controversial.
OBJECTIVE: The objective of this study was to examine the relationship between olfactory dysfunction and disease severity and duration in patients with recently diagnosed parkinsonism and patients with PD with a previous diagnosis.
METHODS: Olfactory function was evaluated in 79 patients with recently diagnosed parkinsonism, 71 patients with PD with a previous diagnosis-with patients in both groups free of cognitive impairment-and 128 age-matched controls. The Odor-Stick Identification Test for Japanese score was counted as the numbers of correct answers, responses of indistinguishable, and responses of odorless. Parkinsonism was evaluated using the Movement Disorder Society Criteria, the Unified Parkinson Disease Rating Scale (UPDRS) Part III, and 123iodine-labeled N-(3-fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl) nortropane single photon emission computed tomography (DaTscan).
RESULTS: In the patients with recently diagnosed parkinsonism having the UPDRS Part III score ≥5 (mean [standard deviation: SD] score: 6.3 [1.9]) and with a positive DaTscan, the mean (SD) numbers of correct answers, responses of indistinguishable and responses of odorless were 4.3 (2.2), 1.6 (2.0), and 1.2 (2.2), respectively. In patients with PD with a previous diagnosis (mean [SD] UPDRS Part III score: 10.9 [3.2]), these numbers were 2.5 (2.2), 2.2 (2.5), and 3.8 (4.6), respectively. The patients with PD with a previous diagnosis showed more significant deterioration than the patients with recently diagnosed parkinsonism in the numbers of correct answers and responses of odorless (P < 0.0001). Olfaction in the combined patient group was significantly impaired compared with age-matched controls in each category (P < 0.0001).
CONCLUSIONS: These findings imply a close association between olfactory dysfunction and disease severity and duration in PD.
© 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  disease duration, disease severity, olfactory dysfunction, Parkinson's disease, parkinsonism

Year:  2020        PMID: 33043078      PMCID: PMC7534008          DOI: 10.1002/mdc3.13028

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  38 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Association of olfactory dysfunction with risk for future Parkinson's disease.

Authors:  G Webster Ross; Helen Petrovitch; Robert D Abbott; Caroline M Tanner; Jordan Popper; Kamal Masaki; Lenore Launer; Lon R White
Journal:  Ann Neurol       Date:  2008-02       Impact factor: 10.422

3.  A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease.

Authors:  Birgit Herting; Susann Schulze; Heinz Reichmann; Antje Haehner; Thomas Hummel
Journal:  J Neurol       Date:  2008-03-19       Impact factor: 4.849

4.  The olfactory and cognitive deficits of Parkinson's disease: evidence for independence.

Authors:  R L Doty; M Riklan; D A Deems; C Reynolds; S Stellar
Journal:  Ann Neurol       Date:  1989-02       Impact factor: 10.422

5.  Olfactory dysfunction in Parkinson's disease.

Authors:  C H Hawkes; B C Shephard; S E Daniel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

Review 6.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

7.  Decline in taste and odor discrimination abilities with age, and relationship between gustation and olfaction.

Authors:  H Kaneda; K Maeshima; N Goto; T Kobayakawa; S Ayabe-Kanamura; S Saito
Journal:  Chem Senses       Date:  2000-06       Impact factor: 3.160

8.  Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study.

Authors:  Naroa Ibarretxe-Bilbao; Carme Junque; Maria-Jose Marti; Francesc Valldeoriola; Pere Vendrell; Nuria Bargallo; Mojtaba Zarei; Eduardo Tolosa
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

9.  High prevalence of parkinsonism in patients with MCI or mild Alzheimer's disease.

Authors:  Shoichi Sasaki
Journal:  Alzheimers Dement       Date:  2018-09-14       Impact factor: 21.566

10.  Olfaction and incident Parkinson disease in US white and black older adults.

Authors:  Honglei Chen; Srishti Shrestha; Xuemei Huang; Samay Jain; Xuguang Guo; Gregory J Tranah; Melissa E Garcia; Suzanne Satterfield; Caroline Phillips; Tamara B Harris
Journal:  Neurology       Date:  2017-09-06       Impact factor: 9.910

View more
  3 in total

1.  High Prevalence of Early Parkinson's Disease in Patients With Subtle Parkinsonian Signs.

Authors:  Shoichi Sasaki
Journal:  Front Neurol       Date:  2021-07-09       Impact factor: 4.003

Review 2.  Molecular and Genetic Factors Involved in Olfactory and Gustatory Deficits and Associations with Microbiota in Parkinson's Disease.

Authors:  Melania Melis; Antje Haehner; Mariano Mastinu; Thomas Hummel; Iole Tomassini Barbarossa
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

Review 3.  Olfactory dysfunction in aging and neurodegenerative diseases.

Authors:  Xiuli Dan; Noah Wechter; Samuel Gray; Joy G Mohanty; Deborah L Croteau; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2021-07-27       Impact factor: 11.788

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.